BJU International

Article	Citations
Is Artificial Intelligence Ready for “Primetime” in Urology?	80
Editorial Board	78
Journal information	78
April's reviewers of the month	64
Editorial Board	61
Eve's and Adam's rib for prostate cancer screening	57
Building a research profile during residency	55
	53
	49
The European Association of Urology talent incubator: bridging competencies for holistic urological care	48
Recent key papers in prostate cancer	42
Author Index	42
April's reviewers of the month	41
MRI, Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	41
A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant?	40
Lower urinary tract electrical sensory assessment: a systematic review and meta‐analysis	39
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	38
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	38
Association between total prostate‐specific antigen (tPSA), free/tPSA, and prostate cancer mortality	35
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	33
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	32
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	32
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	31
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	31
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	30

Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	29
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) and magnetic resonance imaging (MRI) to improve diagnosis of pros	29
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	28
‘Case of the Month’ from Thomas Jefferson University, Philadelphia, PA, USA: a large renal pseudoaneurysm masquerading as advanced renal cell carcinoma	26
Learning curve analysis of single‐port robot‐assisted extraperitoneal prostatectomy using the cumulative sum (CUSUM) method	26
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	26
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	25
The LANDMARK project: providing summaries of key papers that have shaped urological practice	25
Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	25
Response to Chen et al.	24
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	24
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	24
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	23
September's reviewers of the month	23
Progress in the management of stone disease	23
Sustainability in urology – are we doing enough?	23
Table of Contents	23
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	23
Editorial Board	23
Thulium fibre laser lithotripsy, the new standard?	22
	22
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	22
	22
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	21
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	21
	20
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	19
Caval thrombectomy a urological leap into the unknown – a call for action	19
Corrigendum	19
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	19
Is Gleason 6 cancer? The answer is more than just a ‘name’	19
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	19
Can exercise increase natural killer cell infiltration of the prostate?	18
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	18
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway	18
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	18
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	18
The effect of different assays on prostate‐specific antigen testing	18
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	18
The erector spinae plane block can facilitate outpatient stone surgery by reducing breakthrough pain	17
Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?	17
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	17
Journal information	17
Journal information	17
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	17
Can only AI can save us from the burden of administration?	17
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	17
Editorial Board	17
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	17
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	17

A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	17
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	17
Issue Information	17
Re‐defining the interpretation of 24‐h urine studies for stone formers	16
Issue Information	16
Case of the Month from UCSD, San Diego, USA: Treatment of giant dystrophic prostatic calcification using MOSES holmium laser	16
Editorial Board	16
	16
Research Highlights	16
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	16
Editorial Board	16
	16
Cystectomy and lymphadenectomy – we now node how far to go!	16
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	15
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	15
Key ingredients for running a randomised controlled trial in a surgical day unit	15
Clinical presentation of bacille Calmette–Guérin (BCG) infections after BCG instillation therapy	15
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	15
Development of an optically transparent kidney model for laser lithotripsy research	15
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading rates	14
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	14
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of	14
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	14
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	14
TikTok and prostate cancer: misinformation and quality of information using validated questionnaires	13
Acute Urinary Retention and Cancer; Is It All About the Prostate?	13
Renal cell carcinoma and tumour thrombus: devil is in the details of the technique not in the surgical approach	13
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	13
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	13
Table of Contents	13
‘Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and necrotising fasciitis	13
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	13
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	13
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	13
The importance of the urologist in male oncology fertility preservation	13
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	13
Issue Information	12
Table of Contents	12
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	12
Editorial Board	12
Stone volume instead of maximum stone diameter: results from an international survey	12
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	12
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	12
Update from the Canadian Urological Association	12
Recommendation on the use of protective eyewear in endourological laser procedures	12
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	12
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	11
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	11
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	11
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	11
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	11
Perspectives on technology: Single‐use catheters – evidence and environmental impact	11
Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
Neural monitoring of central responses to lower urinary tract function	11
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	11
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	11
Global Urology, Urolink, and the BJUI	11
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation	11
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	11
Emergency department visits for radiation cystitis among patients with a prostate cancer history	11
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer	11
There is more to disposable endoscopes than whether they work…	10
Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre	10
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	10
Editorial Board	10
August's reviewers of the month	10
Editorial Board	10
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	10
Impact of the SARS‐CoV‐2 virus on male reproductive health	10
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE‐IMMUNO study	10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	10
Editorial Board	10
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	10
Editorial Board	10
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	10
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	10
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	10

First‐line programmed death receptor‐1 (PD‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cance	10
January’s reviewers of the month	10
June's reviewers of the month	10
	10
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	9
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	9
Genomic profile – a possible diagnostic and prognostic marker in upper tract urothelial carcinoma	9
A randomised trial comparing transurethral to percutaneous cystolithotripsy in boys	9
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	9
Issue Information	9
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	9
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset	9
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	9
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	9
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	9
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID‐19	9
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	9
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder	9
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	9
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	9
Keith Kirkland Presentation	8
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	8
Outcomes of robot‐assisted urinary sphincter implantation for male neurogenic urinary incontinence	8
The first step in shared decision‐making for prostate cancer screening	8
Villis Marshall Presentation	8
Bladder‐centric benign prostatic hyperplasia management post‐laser enucleation of the prostate	8
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	8
	8
Abstract	8
Table of Contents	8
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	8
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	8
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers	8
Concurrent Session Presentations	8
	8
Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care	8
Working in the Time of a Pandemic – an Australian experience from Junior Doctors and YURO	8
Journal information	8
Journal information	8
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study	8
Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging	8
Journal information	8
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	8
Novel bioabsorbable, low‐dose rate brachytherapy device (CivaSheet®) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancer	8
Case of the Month from Duke University Medical Centre: a complete renal staghorn stone	8
	7
Table of Contents	7
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical prediction	7
Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion	7
Efficacy of indocyanine green fluorescence‐guided inguinal lymph node dissection for penile cancer: a randomised trial	7
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	7
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time	7
Issue Information	7
	7
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	7
Uretero‐enteric stricture outcomes: secondary analysis of a randomised controlled trial comparing open versus robot‐assisted radical cystectomy	7
Molecular margin status after radical prostatectomy using glutathione S‐transferase P1 (GSTP1) promoter hypermethylation	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Post‐prostatectomy anastomotic stenosis: systematic review and meta‐analysis of endoscopic treatment	7
	7
Journal information	7
Is solo indocyanine green‐guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Technetium‐99 m‐sestamibi single‐photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
Confocal laser microscopy for assessment of surgical margins during radical prostatectomy	7
Response to Takahashi	6
Updates on bladder, kidney and prostate cancers	6
Versius robotic surgical system: case series of 18 robot‐assisted radical prostatectomies	6
Risk of severe late toxicity after radiotherapy following radical prostatectomy – a nationwide study	6
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	6
Continence criteria of 193 618 patients after open, laparoscopic, and robot‐assisted radical prostatectomy	6
Reply to ‘Letter Re: Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction’	6
Issue Information	6
Is genetic testing coming of age in advanced prostate cancer?	6
New guidance regarding the diagnosis and risk stratification of patients with prostate cancer	6
	6
Journal information	6
Three‐dimensional virtual reconstruction guides robot‐assisted partial nephrectomy in a horseshoe kidney	6
A systematic review on the outcomes of local anaesthetic transperineal prostate biopsy	6
Electronic medical records – a disappointing mirage for clinicians and research	6
Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft	6
Journal information	6
Positive surgical margins in partial nephrectomy: a collaborative effort to maintain surgical quality	6
Response to Tang et al. ‘Evaluating the efficacy of physiotherapy in post‐prostatectomy continence and pelvic muscle function’	6
Author Index	6
Issue Information	6
Preoperative prediction of high‐risk lymph nodes in penile cancer: Graafland criteria vs radiomics	6
Response to Brönimann et al. 'The Challenges of Conducting a Surgical Trial – Reflectionson the EBRUC II Trial'	6
Is there any difference between cognitive and fusion transrectal biopsies if performed by residents?	6
EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases	6
Table of Contents	6
Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis	6